In an article published in the April 8 issue of Nature, the National Institutes of Health’s Somatic Cell Gene Editing Consortium provided a detailed update on the progress of their nationwide effort to develop safer and more effective methods to edit the genomes of disease-relevant somatic cells and reduce the burden of disease caused by… Read More: PNA-based technique an essential part of the gene editing toolkit »
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity… Read More: FDA Approves Qelbree (viloxazine) for the Treatment of ADHD »
A British trial of the AstraZeneca COVID-19 vaccine involving children has been paused over fears of a possible link to blood clots. Oxford University, who helped develop the vaccine, said in a statement: “Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA (UK regulator) on its… Read More: AstraZeneca pause UK vaccine trial in children »
Regardless of how much you paid for your seat, how much leg room you have or whether you are flying first class or coach, one thing many air travelers have in common is ear discomfort. Ear pressure, popping and even severe pain do not discriminate. While most ear discomfort during air travel is nothing more than… Read More: Airplanes and ear pain: How to avoid it »